DERMIRA INC's ticker is DERM and the CUSIP is 24983L104. A total of 1 filers reported holding DERMIRA INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $173,000 | +183.6% | 11,440 | +20.2% | 0.00% | – |
| Q3 2019 | $61,000 | -33.0% | 9,520 | 0.0% | 0.00% | – |
| Q2 2019 | $91,000 | -8.1% | 9,520 | +30.9% | 0.00% | – |
| Q1 2019 | $99,000 | +135.7% | 7,273 | +24.7% | 0.00% | – |
| Q4 2018 | $42,000 | -33.3% | 5,834 | 0.0% | 0.00% | – |
| Q3 2018 | $63,000 | +16.7% | 5,834 | 0.0% | 0.00% | – |
| Q2 2018 | $54,000 | -3.6% | 5,834 | -17.8% | 0.00% | – |
| Q1 2018 | $56,000 | -79.0% | 7,100 | -25.9% | 0.00% | – |
| Q4 2017 | $267,000 | -3.3% | 9,588 | -6.4% | 0.00% | – |
| Q3 2017 | $276,000 | -1.8% | 10,245 | +6.0% | 0.00% | – |
| Q2 2017 | $281,000 | +19.1% | 9,664 | +40.9% | 0.00% | – |
| Q1 2017 | $236,000 | +32.6% | 6,861 | +16.3% | 0.00% | – |
| Q4 2016 | $178,000 | +119.8% | 5,898 | +134.1% | 0.00% | – |
| Q3 2016 | $81,000 | +1.2% | 2,519 | -7.6% | 0.00% | – |
| Q2 2016 | $80,000 | +45.5% | 2,726 | 0.0% | 0.00% | – |
| Q1 2016 | $55,000 | -41.5% | 2,726 | 0.0% | 0.00% | – |
| Q4 2015 | $94,000 | – | 2,726 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,534,664 | $44,720,000 | 5.35% |
| Avoro Capital Advisors LLC | 1,325,000 | $38,611,000 | 4.88% |
| NEA Management Company, LLC | 3,506,649 | $102,184,000 | 3.72% |
| Iguana Healthcare Management, LLC | 140,000 | $4,080,000 | 2.31% |
| Foresite Capital Management II, LLC | 135,294 | $3,942,000 | 1.81% |
| Foresite Capital Management III, LLC | 176,211 | $5,135,000 | 1.68% |
| Abingworth LLP | 70,000 | $2,038,000 | 1.62% |
| DAFNA Capital Management LLC | 75,500 | $2,200,000 | 1.57% |
| NEXTHERA CAPITAL LP | 120,600 | $3,514,000 | 1.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 129,000 | $3,756,000 | 1.43% |